ERLOLIEVA 150MG TAB (ERLOTINIB TABLETS IP 150MG) -

USD
- INR
- EUR
- - Buyer
    
    Register as a Foriegn Buyer
  - Seller
    
    Log In Register as a Seller

Get Quotations List Products

ERLOLIEVA 150MG TAB (ERLOTINIB TABLETS IP 150MG)

ITC-HSN: 300490

Price on Request

Min Order Qty 1 Bottle

Product not available

Erlotinib Tablets IP 150mg

Brand Name ERLOLIEVA 150MG

Composition Erlotinib Tablets IP 150mg

Manufacture By Allieva Pharma Private Limited

Form Tablet

Packing Btl (30 tab)

Country Of Origin India

RADHAKRUSHNA MEDICALS

Yavatmal, India

Business Operations: Merchant

Contact Seller

Share on:

Agency Request
Distributorship Request
Contract Manufacturing
Joint Venture
Buying Agents
Importers
Business Development Agencies

By clicking on ‘Send Trade Enquiry’, you agree to our terms & condition and user policies

Description
Business Information

Description

ERLOLIEVA contains Erlotinib, an oral targeted anticancer medicine. It is a tyrosine kinase inhibitor (TKI) that selectively blocks the epidermal growth factor receptor (EGFR), thereby inhibiting tumor cell proliferation and survival—especially in EGFR-mutated cancers.

Uses

Erlotinib is used for the treatment of:

Non-small cell lung cancer (NSCLC) – EGFR-mutation positive (first-line or subsequent therapy)

Locally advanced or metastatic NSCLC – after failure of at least one prior chemotherapy regimen

Pancreatic cancer – in combination with gemcitabine

Side Effects

Common side effects:

• Skin rash (acne-like)

• Diarrhea

• Loss of appetite

• Fatigue

• Nausea

Serious side effects:

• Interstitial lung disease (rare but serious)

• Severe skin reactions

• Liver enzyme elevation

• Gastrointestinal perforation (rare)

Dosage

• Standard dose: 150 mg orally once daily

• Take on an empty stomach

(At least 1 hour before or 2 hours after food)

• Dose adjustment may be required based on tolerance or liver function.

NOTE: This medicine should be taken only under a doctor’s supervision.

Prescription Required

Established in:	2021
Bussiness Type:	Sole Proprietorship
Bussiness Type:	Merchant
MSME:	Yes
Countries exporting to:	United States, Philippines, Smaller Territories of the UK, United Kingdom, Bangladesh, Pakistan, Nepal, United Arab Emirates, Australia, Malaysia, Canada, Korea North, Korea South, Thailand, Mexico, Saudi Arabia, Bulgaria, Russia, Poland, Ethiopia, Zimbabwe, Taiwan, Albania, Azerbaijan, Brazil, Tanzania, Bhutan, France, Kuwait, Egypt, Vietnam, Belgium, Belarus, Congo, Czech Republic, Germany, Greece, Greenland, Indonesia, Iran, Israel, Italy, Japan, Jordan, Kenya, Latvia, Lebanon, Liberia, Lithuania, Macedonia, Afghanistan
Export Turnover (3 years):	US$10,000 to US$50,000
Countries would like to export to:	Austria, United States, United Kingdom, Turkey, Thailand, Switzerland, Sri Lanka, South Africa, Bangladesh, Albania, American Samoa, Anguilla, Malaysia, Canada, Korea North, Japan, Korea South, Uzbekistan, Azerbaijan, Bhutan, Belgium, Australia, Afghanistan, Mexico, France, Ethiopia, Germany, Netherlands Antilles, Tanzania, Turks And Caicos Islands, Italy, Bulgaria, Greece, Greenland, Indonesia, Iran, Iraq, Congo, Latvia, Lebanon, Liberia, Lithuania, Kenya, Central African Republic, United Arab Emirates, Philippines, Algeria, Andorra
No of employees:	1-10

ERLOLIEVA 150MG TAB (ERLOTINIB TABLETS IP 150MG)

Related Products

ERLONAT 150MG TAB

Zyceva 150mg

BANDRONE 150MG TAB

Lynparza 150mg

Ramiven 150mg

ERLONAT 100MG TAB

Jollimex 50mg

Medified RELIEF Tab.

Vivitra 440mg

CYSTONE TAB 100s

Glimepiride & Metformin Prolonged release Tablets IP

Isoniazid Tablets IP 100 mg/300 MG